
Adaptimmune Therapeutics plc ADAP
Quartalsbericht 2025-Q2
hinzugefügt 13.08.2025
Adaptimmune Therapeutics plc EV/EBITDA 2011-2026 | ADAP
EV/EBITDA Jährlich Adaptimmune Therapeutics plc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -12.7 | -6.44 | -19.1 K | -36.5 K | -60.8 K | -25.6 K | -343 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -6.44 | -60.8 K | -20.3 K |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | ||
|
Alector
ALEC
|
-44.8 | $ 2.12 | -12.96 % | $ 218 M | ||
|
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
-0.0369 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | ||
|
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
-0.158 | - | -13.39 % | $ 1.45 M | ||
|
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | ||
|
Athira Pharma
ATHA
|
-3.66 | - | - | $ 269 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.807 | - | 17.91 % | $ 11.1 M | ||
|
Altimmune
ALT
|
-1.66 | $ 4.24 | -1.62 % | $ 301 M | ||
|
Arena Pharmaceuticals
ARNA
|
-9.01 | - | -6.81 % | $ 3.04 B | ||
|
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | ||
|
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | ||
|
Athersys
ATHX
|
0.437 | - | 3.77 % | $ 22.4 M | ||
|
Axcella Health
AXLA
|
-0.816 | - | -16.42 % | $ 249 M | ||
|
AstraZeneca PLC
AZN
|
76.5 | - | - | $ 96.9 B | ||
|
AVEO Pharmaceuticals
AVEO
|
-1.76 | - | - | $ 521 M | ||
|
Atreca
BCEL
|
-2.76 | - | -11.76 % | $ 5.79 M | ||
|
AVROBIO
AVRO
|
0.957 | - | 1083.1 % | $ 745 M | ||
|
Agenus
AGEN
|
-8.96 | $ 3.34 | 0.15 % | $ 1.2 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | ||
|
Agios Pharmaceuticals
AGIO
|
-5.08 | $ 28.71 | -5.03 % | $ 1.66 B | ||
|
bluebird bio
BLUE
|
-0.805 | - | - | $ 546 M | ||
|
Brickell Biotech
BBI
|
0.668 | - | -5.38 % | $ 6.06 M | ||
|
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
7.12 | - | - | - | ||
|
Фармсинтез
LIFE
|
-115 | - | - | - |